Current perspective on resectability in stage III locally advanced NSCLC – The thoracic surgeons’ view
Surgical expertise is crucial in determining resectability. Due to differences in surgical expertise, cooperation with other surgical departments, and technical equipment available, a differentiation between "standard resectability" and "resectability with advanced technical requirements" can introduce a clear decision algorithm for interdisciplinary tumorboards. The current 2024 EORTC survey highlights areas with a lack of consensus on surgical indications in stage III NSCLC. T4 NSCLC with involvement of adjacent structures should be managed in high-volume, experienced centers following MDT discussion. Future research should focus on refining selection criteria for surgery and optimize treatment strategies in patients with locally advanced NSCLC.
Authors
- Mir Alireza Hoda (ORCID: https://orcid.org/0000-0002-7088-8768)
- Natalie Baldes (ORCID: https://orcid.org/0000-0002-8719-2206)
- Servet Bölükbas (ORCID: https://orcid.org/0000-0001-8275-5957)
- Merjem Begic (ORCID: https://orcid.org/0000-0002-3488-3118)
- Fabian Doerr (ORCID: https://orcid.org/0000-0002-0878-0406)
- Clemens Aigner (ORCID: https://orcid.org/0000-0002-7787-991X)
Institutions
- Ruhrlandklinik (DE)
- Comprehensive Cancer Center Vienna (AT)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1016/j.ejca.2025.115426
- Citations
- 4
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.07